Korean Circ J.  2016 Nov;46(6):804-810. 10.4070/kcj.2016.46.6.804.

Cardiac Implantable Electronic Device Safety during Magnetic Resonance Imaging

• Hwang YM
• Kim J
• Lee JH
• Kim M
• Nam GB
• Choi KJ
• Kim YH

• KMID: 2355456
• DOI: http://doi.org/10.4070/kcj.2016.46.6.804

Abstract

BACKGROUND AND OBJECTIVES
Although magnetic resonance imaging (MRI) conditional cardiac implantable electronic devices (CIEDs) have become recently available, non-MRI conditional devices and the presence of epicardial and abandoned leads remain a contraindication for MRIs.
SUBJECTS AND METHODS
This was a single center retrospective study, evaluating the clinical outcomes and device parameter changes in patients with CIEDs who underwent an MRI from June 1992 to March 2015. Clinical and device related information was acquired by a thorough chart review.
RESULTS
A total of 40 patients, 38 with a pacemaker (including epicardially located pacemaker leads) and 2 with implantable cardioverter defibrillators, underwent 50 MRI examinations. Among the patients, 11 had MRI conditional CIEDs, while the remaining had non-MRI conditional devices. Among these patients, 23 patients had traditional contraindications for an MRI: (1) nonfunctional leads (n=1, 2.5%), (2) epicardially located leads (n=9, 22.5%), (3) scanning area in proximity to a device (n=9, 22.5%), (4) devices implanted within 6 weeks (n=2, 5%), and (5) MRI field strength at 3.0 Tesla (n=6, 15%). All patients underwent a satisfactory MRI examination with no adverse events during or after the procedure. There were no significant changes in parameters or malfunctioning devices in any patients with CIEDs.
CONCLUSION
Under careful monitoring, MRI is safe to perform on patients with non-MRI conditional CIEDs, remnant leads, and epicardially located leads, as well as MRI-conditional devices.

Keyword

Magnetic resonance imaging; Pacemaker, artificial; Defibrillators, implantable

MeSH Terms

Defibrillators, Implantable
Equipment Safety*
Humans
Magnetic Resonance Imaging*
Pacemaker, Artificial
Retrospective Studies

Reference

1. Erlebacher JA, Cahill PT, Pannizzo F, Knowles RJ. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol. 1986; 57:437–440.

2. Keller J, Neuzil P, Vymazal J, et al. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator. Europace. 2015; 17:761–766.

3. Rickard J, Taborsky M, Bello D, et al. Short- and long-term electrical performance of the 5086MRI pacing lead. Heart Rhythm. 2014; 11:222–229.

4. Bailey WM, Rosenthal L, Fananapazir L, et al. Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2015; 12:1183–1191.

5. Kypta A, Blessberger H, Hoenig S, et al. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI). J Magn Reson Imaging. 2016; 43:574–584.

6. Langman DA, Finn JP, Ennis DB. Abandoned pacemaker leads are a potential risk for patients undergoing MRI. Pacing Clin Electrophysiol. 2011; 34:1051–1053.

7. Misiri J, Kusumoto F, Goldschlager N. Electromagnetic interference and implanted cardiac devices: the nonmedical environment (part I). Clin Cardiol. 2012; 35:276–280.

8. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006; 114:1277–1284.

9. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol. 1996; 19:913–919.

10. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006; 114:1285–1292.

11. Roguin A. Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers. J Am Coll Cardiol. 2009; 54:556–557.

12. Gimbel JR. The safety of MRI scanning of pacemakers and ICDs: what are the critical elements of safe scanning? Ask me again at 10,000. Europace. 2010; 12:915–917.

13. Pohost GM, Johnson LL. Indications for thallium scanning. Heart Dis Stroke. 1992; 1:348–352.

14. Fetter J, Aram G, Holmes DR Jr, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol. 1984; 7:720–727.

15. Pulver AF, Puchalski MD, Bradley DJ, et al. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pacing Clin Electrophysiol. 2009; 32:450–456.

16. Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. 2013; 10:685–691.

17. Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace. 2010; 12:947–951.

18. Wollmann CG, Thudt K, Kaiser B, Salomonowitz E, Mayr H, Globits S. Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE study. J Cardiovasc Magn Reson. 2014; 16:30.

19. Higgins JV, Gard JJ, Sheldon SH, et al. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol. 2014; 37:1284–1290.

20. Sheldon SH, Bunch TJ, Cogert GA, et al. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm. 2015; 12:345–349.

21. Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation. 2013; 128:2799–2809.

22. Wollmann C, Grude M, Tombach B, et al. Safe performance of magnetic resonance imaging on a patient with an ICD. Pacing Clin Electrophysiol. 2005; 28:339–342.

23. Langman DA, Goldberg IB, Finn JP, Ennis DB. Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging. 2011; 33:426–431.

24. Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology. 2004; 232:635–652.

25. Verma A, Ha AC, Dennie C, et al. Canadian Heart Rhythm Society and Canadian Association of Radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices. Can Assoc Radiol J. 2014; 65:290–300.

26. Mitka M. First MRI-safe pacemaker receives conditional approval from FDA. JAMA. 2011; 305:985–986.